{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:44:46Z","timestamp":1762868686740},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Esophageal pleural fistula (EPF) is a rare but fatal complication associated with bevacizumab use; however, cases reports of EPF caused by bevacizumab have not been previously published.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 66-year-old male patient diagnosed with stage IV lung adenocarcinoma on April 24, 2020 received 6 cycles of platinum-containing dual chemotherapy combined with bevacizumab followed by three cycles of bevacizumab monotherapy. Five days before admission, he experienced chest tightness, dyspnea, and right chest pain. Bed-side X-ray examination revealed a massive right hydrothorax, and food was found in the extracted pleural effusion. EPF was further confirmed by upper gastrointestinal radiography after oral administration of iohexol. The patient underwent jejunostomy as the distal esophagus could not be identified on gastroscopy, and eventually died of septic shock on January 16, 2021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is necessary to pay attention to EPF during bevacizumab use in patients with or without risk factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-021-01750-w","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:32:03Z","timestamp":1638297123000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bevacizumab-induced esophageal pleural fistula during maintenance therapy without radiation in lung cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmitananda","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"issue":"5","key":"1750_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S2213-2600(19)30084-0","volume":"7","author":"M Reck","year":"2019","unstructured":"Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, et al. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. Lancet Respir Med. 2019;7(5):387\u2013401. https:\/\/doi.org\/10.1016\/S2213-2600(19)30084-0.","journal-title":"Lancet Respir Med"},{"issue":"26","key":"1750_CR2","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1200\/JCO.19.01006","volume":"37","author":"SS Ramalingam","year":"2019","unstructured":"Ramalingam SS, Dahlberg SE, Belani CP, Saltzman JN, Pennell NA, Nambudiri GS, et al. Pemetrexed, bevacizumab, or the combination as maintenance therapy for advanced nonsquamous non-small-cell lung cancer: ECOG-ACRIN 5508. J Clin Oncol. 2019;37(26):2360\u20137. https:\/\/doi.org\/10.1200\/JCO.19.01006.","journal-title":"J Clin Oncol"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"102017","DOI":"10.1016\/j.ctrv.2020.102017","volume":"86","author":"J Garcia","year":"2020","unstructured":"Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, et al. Bevacizumab (Avastin\u00ae) in cancer treatment: a review of 15 years of clinical experience and future outlook. Cancer Treat Rev. 2020;86:102017. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102017.","journal-title":"Cancer Treat Rev"},{"issue":"17","key":"1750_CR4","doi-asserted-by":"publisher","first-page":"e19878","DOI":"10.1097\/MD.0000000000019878","volume":"99","author":"T Zhang","year":"2020","unstructured":"Zhang T, Yang Y, Cheng G, Chen P, Bi N. Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer: a case report. Medicine (Baltimore). 2020;99(17):e19878. https:\/\/doi.org\/10.1097\/MD.0000000000019878.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1750_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.18999\/nagjms.80.1.129","volume":"80","author":"K Nishie","year":"2018","unstructured":"Nishie K, Yasuo M, Kitaguchi Y, Kobayashi N, Tateishi K, Ushiki A, et al. Bevacizumab-induced tracheoesophageal fistula in a patient suffering from lung cancer with bulky subcarinal lymph node: a case report. Nagoya J Med Sci. 2018;80(1):129\u201334. https:\/\/doi.org\/10.18999\/nagjms.80.1.129.","journal-title":"Nagoya J Med Sci"},{"key":"1750_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clineuro.2018.04.029","volume":"170","author":"LA Zima","year":"2018","unstructured":"Zima LA, Fornoff LE, Surdell DL. Atrioesophageal fistula: considerations for the neurological clinician. Clin Neurol Neurosurg. 2018;170:58\u201360. https:\/\/doi.org\/10.1016\/j.clineuro.2018.04.029.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1750_CR7","doi-asserted-by":"publisher","first-page":"230949901668441","DOI":"10.1177\/2309499016684418","volume":"25","author":"H Yuan","year":"2017","unstructured":"Yuan H, Ding H, Hu L, Buser Z, Zhao H, Li X. Treatment for early postoperative esophageal fistula complicated with anterior cervical surgery. J Orthop Surg (Hong Kong). 2017;25(1):2309499016684418. https:\/\/doi.org\/10.1177\/2309499016684418.","journal-title":"J Orthop Surg (Hong Kong)"},{"issue":"5","key":"1750_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.5946\/ce.2015.48.5.440","volume":"48","author":"JH Kim","year":"2015","unstructured":"Kim JH, Park JJ, Jung IW, Kim SH, Kim HD, Choe JW, et al. Treatment of traumatic esophagopleural fistula using the over-the-scope-clip system. Clin Endosc. 2015;48(5):440\u20133. https:\/\/doi.org\/10.5946\/ce.2015.48.5.440.","journal-title":"Clin Endosc"},{"issue":"4","key":"1750_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jvir.2013.12.015","volume":"25","author":"TH Kim","year":"2014","unstructured":"Kim TH, Shin JH, Kim KR, Park JH, Kim JH, Song HY. Treatment of esophagopleural fistulas using covered retrievable expandable metallic stents. J Vasc Interv Radiol. 2014;25(4):623\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2013.12.015.","journal-title":"J Vasc Interv Radiol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01750-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:35:31Z","timestamp":1638297331000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01750-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01750-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s son for publication of any potentially identifying images and clinical details of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}